Topical Agent for Treatment of Red Skin

Mayo Clinic20 enrolled

Overview

SR-01 may reduce facial redness. it is a topically applied product. The agent will be applied to local skin areas of subjects with red facial skin to assess affect, and then applied to the whole face to assess efficacy and safety

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Rosacea Bilaterally Symmetric Red Skin on Cheeks

Interventions

Topical SR-01DRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 Years

Medical Language ↔ Plain English

Bilaterally symmetric red skin on cheeks Caucasian Age 18-60 years

Locations (1)

Mayo Clinic

Scottsdale, Arizona, United States

Outcomes

Primary Outcomes

Reduction of redness

Secondary Outcomes

Safety and tolerability

Cosmetic acceptability

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.